<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are clonal disorders of hematopoietic stem cell </plain></SENT>
<SENT sid="1" pm="."><plain>Patients have a deteriorating course with about 30% evolving into <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> usually of the myeloid phenotype </plain></SENT>
<SENT sid="2" pm="."><plain>Evolution into <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> is a rare and intriguing phenomenon seen in far less than 1% of adult cases, and extremely rare in pediatric population </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case of childhood <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> transforming into <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> after an interval of 21 months since presentation and being on <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> therapy for 9.5 months </plain></SENT>
<SENT sid="4" pm="."><plain>The case raises further questions about the biology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and the potential role of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> in leukemic transformation </plain></SENT>
</text></document>